Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.3B | 4.9B | 4.8B | 4.6B |
Cost of revenue | 3.5B | 4.0B | 3.9B | 3.6B |
Gross profit | 740M | 989M | 943M | 948M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 650M | 692M | 663M | 731M |
Other operating expenses | — | — | — | — |
Operating income | 90M | 297M | 280M | 217M |
Non operating interest income | ||||
Income | 10M | 13M | 14M | 12M |
Expense | 115M | 131M | 135M | 130M |
Other income expense | 161M | -72M | -168M | 57M |
Pretax income | 131M | 92M | -25M | 140M |
Tax provision | 13M | 20M | 9M | 60M |
Net income | 118M | 72M | -34M | 80M |
Basic EPS | 0.4 | 0.3 | -0.1 | 0.3 |
Diluted EPS | 0.4 | 0.3 | -0.1 | 0.3 |
Basic average shares | 287M | 287M | 287M | 287M |
Diluted average shares | 289M | 288M | 287M | 288M |
EBITDA | 331M | 520M | 499M | 451M |
Net income from continuing op. | 118M | 72M | -34M | 80M |
Minority interests | -3M | 4M | 0 | 5M |
Preferred stock dividends | — | — | — | — |